Crossmark

Post-transplantation gilteritinib maintenance therapy and therapeutic drug monitoring in pediatric acute myeloid leukemia with FLT3–internal tandem duplication

Crossref DOI link: https://doi.org/10.1007/s00280-025-04860-y

Published Online: 2026-01-20

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yanagimachi, Masakatsu

Iwano, Reiko

Keino, Dai

Kimizuka, Yu

Kurita, Daisuke

Hayashi, Akiko

Miyagawa, Naoyuki

Yokosuka, Tomoko

Hamanoue, Satoshi

Iwasaki, Fuminori

Goto, Hiroaki
Funding

Funding for this research was provided by:

Kanagawa Prefectural Hospitals Cancer Fund

Kanagawa Children’s Medical Center Research Foundation
License Information

Text and Data Mining valid from 2026-01-20

Version of Record valid from 2026-01-20
More Information

Article History

Received: 28 September 2025

Accepted: 13 December 2025

First Online: 20 January 2026

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below